PHOENIX, Ariz., May 03, 2018 -- US Nuclear Corp. (OTCBB:UCLE) (the “Company”), a manufacturer of high-tech sensors, drones and medical devices, today announced CEO Bob Goldstein’s interview on Uptick Newswire’s “Stock Day” podcast with Everett Jolly.
US Nuclear Corp. specializes in radiation detection, from which it expanded into fitting drones with cameras, radiation and chemical sensors. These drones, sold in the US and abroad, serve Homeland Security, the US military and are used in search and rescue.
“I am excited to have you on the show, I have been watching your company for about six-months now.” commented Jolly. “US Nuclear Corp. has dominated radiation and chemical detection, which led to your highly successful footprint in the drone space. Now using your vast experience with radiation, the Company is working with medical isotopes for cancer screening and treatment. Can you tell me about the size and saturation of the market, and how US Nuclear is going to be a disruptor?”
“Medical isotopes are key for many medical procedures, especially in diagnostic scanning that the doctor needs in order to understand and successfully treat your disease. There is already a shortage in the medical isotope cocktail which uses the medical isotopes.” said Goldstein. “The $10 billion market is slated to be $15 billion in four years-time. The volume of the world’s supply is dropping rapidly; US Nuclear Corp. is in development of a device capable of producing these substances on site.”
“When do you think you are going to introduce this product to market?” asked Jolly.
“We are about two years from market,” said Goldstein. “Medical isotopes are currently produced in large nuclear reactors in four countries; however, those devices take a staff of hundreds of people. Our product will take a staff of two or three and we believe we will produce this material at half the price.”
To listen to the full interview please click here to the following link: https://upticknewswire.com/featured-interview-ceo-robert-goldstein-of-us-nuclear-corp-otcpink-ucle/
About US Nuclear Corp.
US Nuclear Corp is a fully-reporting, publicly traded company on the Over-the-Counter Bulletin Board, traded under the ticker symbol UCLE. The Company's operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The Company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others.
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (OTCBB:UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: [email protected]
About Uptick Newswire and the “Stock Day Podcast”
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona.
Investors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit US Nuclear Corp., message board on: https://investorshangout.com/
Source: Uptick Newswire


Luxury Stocks Face Volatility as AI Market Swings and Hedge Fund Bets Rattle LVMH and Kering
Microsoft Responds to ICE Surveillance Concerns Amid Azure Cloud Expansion
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand
OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report
Freedom Finance and Binance Join Forces in Digital Assets
Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump
Airbus Cuts Jet Production Target Amid Pratt & Whitney Engine Shortages, Q4 Profit Jumps 17%
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 



